Skip to main content Skip to main navigation menu Skip to site footer

Analysis of donor hemoglobin levels at the blood transfusion service of Dr. Sardjito Hospital, Yogyakarta

  • Usi Sukorini ,
  • Galih Retno Martani ,
  • Teguh Triyono ,

Abstract

Introduction: Blood service is a health service that utilizes human blood as a basic ingredient for humanitarian and non-commercial purposes. Donors in Indonesia are required to have a minimum Hemoglobin (Hb) level of 12.5 g/dL in accordance with National Regulations. It aims to ensure that the donor can tolerate the loss of blood without the appearance of anemia symptoms. This study aims to analyze the Hb levels of donors at the Blood Transfusion Service of Dr. Sardjito Hospital, Yogyakarta, Indonesia.

Method: This analytic observational study applied a retrospective design. The data of 62,221 donors were taken from the donor database of the Blood Transfusion Service of Dr. Sardjito Hospital. The inclusion criteria were donors aged ≥ 17 years and met other donor selection criteria. Donors with incomplete data were excluded. The chi-Square test was performed using the SPSS version 22. The p < 0.05 was considered significant.

Results: The subjects were dominated by male donors, i.e., 48,348 (77.7%), and the most Hb level were 14.1-15.5 g/dL. This range of Hb levels was identified as the highest proportion in all age groups. The Hb levels of 14.1-15.5 g/dL were determined in 5,874 (39.6%) blood group A, 7,332 (39%) blood group B; 1,830 (39.6%) blood group AB and 9,486 (39.5%) blood group O donors.

Conclusions: There was a significant difference in the proportion of donors based on Hb levels, sexes, ABO groups, Rhesus D groups, donation types, and donor statuses (p < 0.001).

References

  1. Haslinda HI, Maryuningsih YS. Pelayanan Darah di Indonesia. Kemenkes RI. 2018:1–10.
  2. Blood Donor Selection: Guidelines on Assessing Donor Suitability for Blood Donation. Geneva: World Health Organization. 2012:1–230. ISBN: 9789241548519.
  3. Menteri Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 91. 2015:1–268.
  4. Boulton F. Evidence-based criteria for the care and selection of blood donors, with some comments on the relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transfus Med. 2008;18(1):13-27. doi: 10.1111/j.1365-3148.2007.00818.x.
  5. Zalpuri S, Romeijn B, Allara E, Goldman M, Kamel H, Gorlin J, Vassallo R, Grégoire Y, Goto N, Flanagan P, Speedy J, Buser A, Kutner JM, Magnussen K, Castrén J, Culler L, Sussmann H, Prinsze FJ, Belanger K, Compernolle V, Tiberghien P, Cardenas JM, Gandhi MJ, West KA, Lee CK, James S, Wells D, Sutor LJ, Wendel S, Coleman M, Seltsam A, Roden K, Steele WR, Bohonek M, Alcantara R, Di Angelantonio E, van den Hurk K; BEST Collaborative Study Group. Variations in hemoglobin measurement and eligibility criteria across blood donation services are associated with differing low-hemoglobin deferral rates: a BEST Collaborative study. Transfusion. 2020;60(3):544-552. doi: 10.1111/trf.15676.
  6. Patel AJ, Wesley R, Leitman SF, Bryant BJ. Capillary versus Venous Haemoglobin Determination in the Assessment of Healthy Blood Donors. Vox Sang. 2013 May;104(4):317-23. doi: 10.1111/vox.12006.
  7. Eder A, Goldman M, Rossmann S, Waxman D, Bianco C. Selection Criteria to Protect the Blood Donor in North America and Europe: Past (Dogma), Present (Evidence), and Future (Hemovigilance). Transfus Med Rev. 2009 Jul;23(3):205-20. doi: 10.1016/j.tmrv.2009.03.003.
  8. Cable RG, Brambilla D, Glynn SA, Kleinman S, Mast AE, Spencer BR, Stone M, Kiss JE; National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Effect of Iron Supplementation on Iron Stores and Total Body Iron after Whole Blood Donation. Transfusion. 2016;56(8):2005-12. doi: 10.1111/trf.13659.
  9. Kiss JE, Birch RJ, Steele WR, Wright DJ, Cable RG. Quantification of Body Iron and Iron Absorption in the REDS-II Donor Iron Status Evaluation (RISE) Study. Transfusion. 2017;57(7):1656-1664. doi: 10.1111/trf.14133.
  10. Astuti Y, Artini D. Comparative Hemoglobin and Hematocrit Before and After Donation To Blood Donate in Unit Transfusion Yogyakarta City. JRK. 2019;8(2):40–41. doi:10.31983/jrk.v8i2.5362.
  11. Valerian DM, Mauka WI, Kajeguka DC, Mgabo M, Juma A, Baliyima L, Sigalla GN. Prevalence and causes of blood donor deferrals among clients presenting for blood donation in northern Tanzania. PLoS One. 2018;13(10):e0206487. doi: 10.1371/journal.pone.0206487.
  12. Koram SK, Sadula M, Veldurthy VS. Distribution of ABO and Rh-blood groups in blood donors at teritiary care centre. Int J Res Med Sci. 2014;2(1):326–330. ISSN (o):2321–7251.
  13. Prados Madrona D, Fernández Herrera MD, Prados Jiménez D, Gómez Giraldo S, Robles Campos R. Women as whole blood donors: offers, donations and deferrals in the province of Huelva, south-western Spain. Blood Transfus. 2014;1(1):11-20. doi: 10.2450/2012.0117-12.
  14. Bain NJ. Rodak’s Hematology Clinical Principles and Applications by Keohane EM, Smith LJ, Walenga JM, Elsevier, St Louis. British Journal of Haematology. 2016;177(4):662. doi: 10.1111/bjh.14687.
  15. Schotten N, Pasker-de Jong PC, Moretti D, Zimmermann MB, Geurts-Moespot AJ, Swinkels DW, van Kraaij MG. The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism. Blood. 2016;128(17):2185-2188. doi: 10.1182/blood-2016-04-709451.
  16. Mast AE. Low Hemoglobin Defferal in Blood Donors. ransfus Med Rev. 2014 Jan;28(1):18-22. doi: 10.1016/j.tmrv.2013.11.001.
  17. Cable RG. Hemoglobin determination in blood donors. Transfus Med Rev. 1995;9(2):131-44. doi: 10.1016/s0887-7963(05)80052-5.
  18. Charbonneau J, Cloutier MS, Carrier É. Whole blood and apheresis donors in Quebec, Canada: Demographic differences and motivations to donate. Transfus Apher Sci. 2015;53(3):320-8. doi: 10.1016/j.transci.2015.06.001.
  19. Triyono T, Fridawati V, Sukorini U, Mulyono B. Safe Blood and Voluntary Non-Remunerated Blood Donors. Indo J Clinical Pathol Med Laboratory. 2014;21(1):20. doi:10.24293/ijcpml.v21i1.1253.
  20. Sharma S, sharma dharmesh chandra, Rai S, Arya A, Jain R, Kaur D, Jain B. Prevalence of ABO, RhD and other clinically significant Blood Group Antigens among blood donors at tertiary care center, Gwalior. Bali Med J. [Internet]. 2020 Aug. 1 [cited 2023 Jul. 1];9(2):437-43. Available from: https://www.balimedicaljournal.org/index.php/bmj/article/view/1779.
  21. Betti Bettavia Hartama Pardosi, Ni Kadek Mulyantari, Ida Ayu Putri Wirawati, Anak Agung Wiradewi Lestari, Ni Nyoman Mahartini. Overview of transfusion reactions in patients with incompatible crossmatch at Sanglah General Hospital, Denpasar, Bali, Indonesia. Bali Med J. [Internet]. 2022 May 31 [cited 2023 Jul. 1];11(2):506-9. Available from: https://www.balimedicaljournal.org/index.php/bmj/article/view/3605.
  22. Pradypta PG, Titien I, WM PK. Relationship between the amount of blood transfusion and the amount of iron chelation with blood and salivary ureum levels in children with beta thalassemia major. Bali Med J. [Internet]. 2022 Dec. 30 [cited 2023 Jul. 1];11(3):2043-7. Available from: https://www.balimedicaljournal.org/index.php/bmj/article/view/3488.

How to Cite

Sukorini, U., Galih Retno Martani, & Teguh Triyono. (2023). Analysis of donor hemoglobin levels at the blood transfusion service of Dr. Sardjito Hospital, Yogyakarta. Bali Medical Journal, 12(2), 2191–2195. https://doi.org/10.15562/bmj.v12i2.4617

HTML
15

Total
9

Share

Search Panel